Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the ‘AIRE’ multicentre study
This RWE study showed that ADA and IXE provide similar 12-month joint outcomes, while IXE showed a faster skin response. Baseline demographic and clinical features affect the chance of remission, highlighting the importance of personalised treat-to-target approaches in PsA.
Institutions
- Marche Polytechnic University (IT)
- University of Udine (IT)
- University of Molise (IT)
- University of Padua (IT)
- University of Chieti-Pescara (IT)
- Ospedale Garibaldi (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- RMD Open
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1136/rmdopen-2025-006667
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00